[EN] NOVEL PSYMBERIN DERIVATIVES, COMPOSITIONS, AND THEIR USE AS ANTINEOPLASTIC AGENTS<br/>[FR] NOUVEAUX DÉRIVÉS ET COMPOSITIONS DE PSYMBÉRINE ET LEUR UTILISATION EN TANT QU'AGENTS ANTINÉOPLASIQUES
申请人:SCHERING CORP
公开号:WO2009158381A1
公开(公告)日:2009-12-30
The present invention provides compounds according to Formula (I): or pharmaceutically acceptable salts, solvates, esters, prodrugs, tautomers, and isomers thereof, wherein: ring A, n, q, R1, R2, R3, R4, R5, R6, each R7, each R7A, and R8 are each selected independently of each other and as defined herein. The invention also provides pharmaceutical compositions comprising such compounds (optionally in combination with one or more additional active ingredients), and methods for their use in treating or preventing a wide range of cancers.
本发明提供了根据式(I)的化合物:或其药学上可接受的盐、溶剂化合物、酯、前药、互变异构体和同分异构体,其中:环A、n、q、R1、R2、R3、R4、R5、R6、每个R7、每个R7A和R8各自独立地选择,并按照所述定义。本发明还提供包括这些化合物的药物组合物(可选地与一个或多个额外活性成分结合),以及在治疗或预防各种癌症中使用它们的方法。